Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) belongs to Healthcare sector. Its weekly performance is 60.43%. On last trading day company shares ended up $3.69. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) distance from 50-day simple moving average (SMA50) is 40.09%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), Monday announced positive final results from a Phase II investigator sponsored clinical trial of OHR-102 in patients with macular edema secondary to branch or BRVO and central retinal vein occlusion or CRVO.
XOMA Corporation (NASDAQ:XOMA) shares moved down -6.57% in last trading session and ended the day at $4.41. XOMA return on assets is -67.30%. XOMA Corporation (NASDAQ:XOMA) quarterly performance is 12.50%. Wedbush reissued their outperform rating on shares of XOMACorp (NASDAQ:XOMA) in a research report released on Tuesday morning, MarketBeat.Com reports. Wedbush currently has a $17.00 price objective on the stock.
On 13 July, Gilead Sciences Inc. (NASDAQ:GILD) shares advanced 0.71% and was closed at $114.55. GILD EPS growth in last 5 year was 39.10%. Gilead Sciences Inc. (NASDAQ:GILD) year to date (YTD) performance is 21.97%. On 1st July, Gilead Sciences, Inc. (NASDAQ:GILD) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for an investigational, once-daily single tablet regimen that combines Gilead’s emtricitabine 200 mg and tenofovir alafenamide (TAF) 25 mg with rilpivirine 25 mg (R/F/TAF) from Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the treatment of HIV-1 infection in adult and pediatric patients 12 years of age and older.
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) ended the last trading day at $131.93. Company weekly volatility is calculated as 7.73% and price to cash ratio as 33.00. Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) showed a weekly performance of 65.41%. Anacor Pharmaceuticals Inc’s (NASDAQ: ANAC) experimental skin ointment succeeded in late-stage studies, taking the drugmaker a step closer to having a potential blockbuster in its portfolio and raising expectations that it could be taken over.
MannKind Corp. (NASDAQ:MNKD) shares advanced 3.53% in last trading session and ended the day at $5.57. MNKD return on assets is -66.50%. MannKind Corp. (NASDAQ:MNKD) quarterly performance is 7.32%.